News
5hon MSN
Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...
12hon MSN
Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...
Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...
8h
Distractify on MSNA Mammoth Endeavor: Colossal Biosciences Merges Artificial Intelligence With Showbiz to Revive Extinct Species.Colossal Biosciences, powered by AI and amplified by Hollywood's megaphone, is proving that the story of extinction doesn't ...
This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...
The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...
Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...
The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment is expected to be ...
Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.
1d
Zacks Investment Research on MSNWhy Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates AgainLooking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...
Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results